Equillium, Inc. (EQ) Form 10-Q — May 13, 2026
Equillium, Inc. reported a net loss of $5.3 million for the three months ended March 31, 2026, compared to a net loss of $8.7 million for the same period in 2025. The decrease in net loss is primarily due to a reduction in research and development expenses, which fell from $5.9 million to $3.0 million. The company completed a private placement in March 2026, raising gross proceeds of $35.0 million.
Key figures
- Eps Beat
- 0
- Revenue
- 0
- Total Debt
- 3596
- Debt Amount
- 0
- Revenue Yoy
- 0
- Total Assets
- 63083
- Cash Position
- 61322
- Deal Value Usd
- 0
- Interest Rate
- 0
- Gross Proceeds
- 35000
- Offering Price
- 1.854
- Shares Offered
- 1179508
- Shares Outstanding
- 63226556
- Pre funded warrants
- 17698593
- Pre funded warrant price
- 1.8539
Price after filing
1 day: +12.1%7 days: -10.8%30 days: +21.6%
Close on the filing date to close N calendar days later (from $2.31). Historical, not a forecast.
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.